Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E7FS
|
||||
Former ID |
DAP001251
|
||||
Drug Name |
Adinazolam
|
||||
Synonyms |
Adinazolamum; Deracyn; Adinazolam [USAN]; U 41123; Adinazolamum [INN-Latin]; Deracyn (TN); U 41,123;U-41123; Adinazolam (USAN/INN); Adinazolam [USAN:BAN:INN]; 1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine; 8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine; 8-chloro-1-[(dimethylamino)methyl]-6-phenyl-4h-s-triazolo[4,3-a][1,4]benzodiazepine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder; Status epilepticus [ICD9: 300, 345.3; ICD10:F40-F42, G40] | Approved | [550684] | ||
Therapeutic Class |
Antidepressants
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H18ClN5
|
||||
Canonical SMILES |
CN(C)CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
|
||||
InChI |
1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3
|
||||
InChIKey |
GJSLOMWRLALDCT-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 37115-32-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
8175130, 12013114, 14852028, 17396928, 34678912, 46509054, 48179686, 48404442, 50064737, 50874613, 57312080, 85444484, 103304585, 104327089, 117469085, 127963782, 134223599, 134338488, 134999582, 136350410, 137005585, 160963891, 179150397, 184545903, 198955325, 224774472, 226421674, 250138438, 252344773
|
||||
SuperDrug ATC ID |
N05BA07
|
||||
SuperDrug CAS ID |
cas=037115325
|
||||
Target and Pathway | |||||
Target(s) | Peripheral-type benzodiazepine receptor | Target Info | Agonist | [534872] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
HTLV-I infection | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.